Immune Design Corp. said Peter Svennilson resigned as the company's director, effective Aug. 31.

Svennilson joined the company's board in March 2013. Immune Design noted that his resignation was not due to any disagreement with the company's operations, policies or practices.

Seattle-based Immune Design is an immunotherapy company developing in vivo cancer treatments.